Biochip Firm Lumera Registers for IPO; Stands to Gain $28 Million | GenomeWeb

NEW YORK, May 28 (GenomeWeb News) - Lumera, a majority owned subsidiary of Microvision, has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering of 5 million shares of its common stock.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.